Laman UtamaSHTDY • OTCMKTS
add
Sinopharm Group ADR
Tutup sebelumnya
$10.84
Julat hari
$11.10 - $11.45
Julat tahun
$10.13 - $16.31
Permodalan pasaran
56.73B HKD
Bilangan Purata
27.00K
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (CNY) | Dis 2024info | Perubahan T/T |
|---|---|---|
Hasil | 144.89B | -3.82% |
Perbelanjaan pengendalian | 6.44B | 15.96% |
Pendapatan bersih | 1.67B | -43.43% |
Margin untung bersih | 1.15 | -41.33% |
Pendapatan bagi setiap syer | — | — |
EBITDA | 5.32B | -35.75% |
Kadar cukai berkesan | 29.36% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (CNY) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 54.31B | -19.10% |
Jumlah aset | 392.83B | 2.46% |
Jumlah liabiliti | 266.14B | 1.17% |
Jumlah ekuiti | 126.69B | — |
Syer tertunggak | 3.12B | — |
Harga kepada buku | 0.43 | — |
Pulangan pada aset | 3.00% | — |
Pulangan pada modal | 5.81% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (CNY) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 1.67B | -43.43% |
Tunai daripada operasi | 26.27B | 43.57% |
Tunai daripada pelaburan | -1.36B | 69.47% |
Tunai daripada pembiayaan | -19.42B | -266.23% |
Perubahan bersih dalam tunai | 5.49B | -78.50% |
Aliran tunai bebas | 3.14B | -92.00% |
Perihal
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Diasaskan
2003
Tapak web
Pekerja
108,217
